HAMP and COVID-19: Nonetheless, hepcidin showed a sensitivity of 74% and a specificity of 76%, at a cut-off value of >127 ng/mL, suggesting that hepcidin measurement is a useful biomarker for predicting the severity and the outcome of COVID-19 in ICU patients.